bristol-myers glp-1 receptor agonist products Five Unexpected New Uses for Agonists Trends in the Development of
Description
Goyal, Y
Oh YS, Jun HS
Histologically, lobular inflammation with hepatocyte ballooning in zone 3 is typical of adult MASLD (type 1 MASH)
These milestones highlight the growing regulatory and clinical momentum supporting expanded uses Ongoing trials are also exploring the impact of GLP-1 agonists on cardiovascular outcomes, liver health, and even neurodegenerative diseases, reinforcing their value in treating systemic metabolic disorders
These combined effects help regulate blood glucose levels and reduce food intake
